Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Cerus Corporation stock
Learn how to easily invest in Cerus Corporation stock.
Cerus Corporation is a medical devices business based in the US. Cerus Corporation shares (CERS) are listed on the NASDAQ and all prices are listed in US Dollars. Cerus Corporation employs 631 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Cerus Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CERS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cerus Corporation stock price (NASDAQ: CERS)Use our graph to track the performance of CERS stocks over time.
Cerus Corporation shares at a glance
|Latest market close||$5.29|
|52-week range||$4.35 - $8.06|
|50-day moving average||$4.95|
|200-day moving average||$5.80|
|Wall St. target price||$9.40|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.29|
Buy Cerus Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cerus Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cerus Corporation price performance over time
|1 week (2022-06-24)||-4.68%|
|1 month (2022-06-01)||9.30%|
|3 months (2022-03-31)||-3.64%|
|6 months (2021-12-30)||-23.99%|
|1 year (2021-07-02)||-5.70%|
|2 years (2020-07-02)||-21.75%|
|3 years (2019-07-02)||1.34%|
|5 years (2017-06-30)||110.76%|
Cerus Corporation financials
|Revenue TTM||$144.9 million|
|Gross profit TTM||$67.4 million|
|Return on assets TTM||-11.96%|
|Return on equity TTM||-56.87%|
|Market capitalisation||$935.8 million|
TTM: trailing 12 months
Cerus Corporation share dividends
We're not expecting Cerus Corporation to pay a dividend over the next 12 months.
Cerus Corporation share price volatility
Over the last 12 months, Cerus Corporation's shares have ranged in value from as little as $4.35 up to $8.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cerus Corporation's is 1.2123. This would suggest that Cerus Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Cerus Corporation overview
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California. .
Cerus Corporation in the news
Wall Street Analysts See an 89% Upside in Cerus (CERS): Can the Stock Really Move This High?
Cerus Corporation Celebrates World Blood Donor Day 2022
Does Cerus (CERS) Have the Potential to Rally 88% as Wall Street Analysts Expect?
Frequently asked questionsWhat percentage of Cerus Corporation is owned by insiders or institutions?
Currently 3.192% of Cerus Corporation shares are held by insiders and 80.859% by institutions. How many people work for Cerus Corporation?
Latest data suggests 631 work at Cerus Corporation. When does the fiscal year end for Cerus Corporation?
Cerus Corporation's fiscal year ends in December. Where is Cerus Corporation based?
Cerus Corporation's address is: 1220 Concord Avenue, Concord, CA, United States, 94520 What is Cerus Corporation's ISIN number?
Cerus Corporation's international securities identification number is: US1570851014 What is Cerus Corporation's CUSIP number?
Cerus Corporation's Committee on Uniform Securities Identification Procedures number is: 157085101
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert